MetaProteomics
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, MetaProteomics sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,751 sponsors by registered trial count).
MetaProteomics: 4 sponsored US clinical trials, none currently recruiting.
MetaProteomics sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 3 completed. The most-studied condition in this pipeline is Obesity, with 1 trials.
Upper-quartile sponsor footprint
MetaProteomics sits in the upper quartile of the sponsor corpus (#2,913 of 15,751 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Effect of Citrus Bioflavonoids/Vitamin E in Conjunction With Fish Oil Supplementation
NCT01671254
Effect of a Novel Nutraceutical on Weight Loss and Weight Maintenance in Obese Subjects
NCT01656681
Effects of a Novel Dietary Intervention on Body Composition After Laparoscopic Gastric Bypass Surgery
NCT01041261
Trial of Two Dietary Programs on Cardiometabolic Risk Factors in Subjects With Metabolic Syndrome
NCT01010841
Therapeutic Areas
How the MetaProteomics archive is shaped
4 indexed studies, none listed as recruiting (0% open); 3 completed (75%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Obesity (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.